Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,283 | 186 | 75.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $900.00 | 3 | 20.6% |
| Education | $185.52 | 10 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $826.13 | 46 | $0 (2023) |
| Celularity Inc. | $600.00 | 2 | $0 (2021) |
| PFIZER INC. | $331.33 | 18 | $0 (2023) |
| Duchesnay USA Incorporated | $312.61 | 16 | $0 (2019) |
| Celularity BioSourcing, LLC | $300.00 | 1 | $0 (2018) |
| TherapeuticsMD, Inc. | $295.70 | 18 | $0 (2022) |
| Allergan, Inc. | $248.68 | 18 | $0 (2020) |
| Exeltis, USA Inc. | $219.79 | 13 | $0 (2024) |
| Astellas Pharma US Inc | $174.15 | 6 | $0 (2024) |
| Roche Diagnostics Corporation | $167.58 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $313.67 | 11 | Astellas Pharma US Inc ($174.15) |
| 2023 | $251.25 | 12 | PFIZER INC. ($98.01) |
| 2022 | $246.75 | 14 | ABBVIE INC. ($92.46) |
| 2021 | $702.69 | 22 | Celularity Inc. ($300.00) |
| 2020 | $224.57 | 13 | TherapeuticsMD, Inc. ($57.59) |
| 2019 | $1,171 | 50 | Celularity, Inc. ($300.00) |
| 2018 | $949.49 | 41 | Celularity BioSourcing, LLC ($300.00) |
| 2017 | $508.43 | 36 | PFIZER INC. ($60.12) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Biological | ||||||
| 10/09/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $41.37 | General |
| Category: Hematology | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Biological | ||||||
| 08/05/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: HORMONE THERAPY | ||||||
| 05/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Biological | ||||||
| 05/15/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: CONTRACEPTIVE | ||||||
| 04/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Biological | ||||||
| 03/12/2024 | Medtronic, Inc. | TRUCLEAR (Device) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: Hysteroscopy Systems | ||||||
| 02/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Biological | ||||||
| 02/05/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
| 12/06/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Oral Contraceptive | ||||||
| 11/16/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: WOMENS HEALTH | ||||||
| 10/25/2023 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: WOMENS HEALTH | ||||||
| 10/06/2023 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: VACCINES | ||||||
| 09/06/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: WOMENS HEALTH | ||||||
| 08/11/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: WOMENS HEALTH | ||||||
| 06/21/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: WOMENS HEALTH | ||||||
| 04/27/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: WOMENS HEALTH | ||||||
| 04/20/2023 | Mycovia Pharmaceuticals, Inc. | Vivjoa (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/12/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: HORMONE THERAPY | ||||||
| 03/03/2023 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: WOMENS HEALTH | ||||||
| 02/21/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: WOMENS HEALTH | ||||||
| 11/18/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: WOMENS HEALTH | ||||||
| 11/09/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: ETONOGESTREL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 620 | 637 | $70,835 | $34,799 |
| 2022 | 7 | 563 | 572 | $61,965 | $29,480 |
| 2021 | 7 | 740 | 747 | $64,330 | $31,671 |
| 2020 | 9 | 902 | 920 | $81,975 | $33,130 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 194 | 196 | $44,100 | $21,082 | 47.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 111 | 111 | $8,325 | $5,250 | 63.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 59 | 59 | $3,540 | $2,993 | 84.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 25 | $4,375 | $1,776 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,750 | $1,550 | 56.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 29 | $3,625 | $1,446 | 39.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 203 | 206 | $4,120 | $702.46 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 186 | 188 | $42,300 | $19,498 | 46.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 105 | 105 | $7,875 | $5,227 | 66.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 35 | 35 | $2,100 | $1,851 | 88.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 18 | $3,150 | $1,251 | 39.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 20 | $2,500 | $931.97 | 37.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 189 | 190 | $3,800 | $652.81 | 17.2% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 16 | 16 | $240.00 | $69.44 | 28.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 188 | 190 | $42,750 | $20,760 | 48.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 96 | 96 | $7,200 | $4,701 | 65.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 51 | 51 | $3,060 | $2,731 | 89.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 14 | $2,450 | $1,072 | 43.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 18 | $2,250 | $922.42 | 41.0% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 188 | 188 | $2,820 | $823.44 | 29.2% |
| 81002 | Urinalysis, manual test | Office | 2021 | 190 | 190 | $3,800 | $661.20 | 17.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 215 | 217 | $48,825 | $16,962 | 34.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 141 | 141 | $10,175 | $7,041 | 69.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 54 | 54 | $3,240 | $2,791 | 86.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $3,000 | $1,827 | 60.9% |
About Dr. Peter Simonson, MD
Dr. Peter Simonson, MD is a Obstetrics & Gynecology healthcare provider based in Suffern, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811973258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Simonson, MD has received a total of $4,368 in payments from pharmaceutical and medical device companies, with $313.67 received in 2024. These payments were reported across 199 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,283).
As a Medicare-enrolled provider, Simonson has provided services to 2,825 Medicare beneficiaries, totaling 2,876 services with total Medicare billing of $129,080. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Suffern, NY
- Active Since 12/19/2005
- Last Updated 02/24/2012
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811973258
Products in Payments
- LO LOESTRIN FE (Drug) $580.31
- Orilissa (Drug) $313.21
- PREMARIN (Drug) $252.23
- Bonjesta (Drug) $206.45
- RS Harmony Test Related Products (Device) $131.37
- SLYND (Drug) $119.05
- IMVEXXY (Drug) $110.08
- INTRAROSA (Drug) $106.68
- Veozah (Drug) $99.16
- ANNOVERA (Drug) $97.26
- BIJUVA (Drug) $88.36
- Balcoltra (Drug) $86.23
- ORILISSA (Drug) $82.74
- MYFEMBREE (Drug) $76.93
- Osphena (Drug) $74.15
- Kyleena (Drug) $68.22
- Diclegis (Drug) $61.97
- Prenate Mini (Drug) $52.90
- Vitafol Ultra (Drug) $46.02
- PICO (Device) $43.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Suffern
Patricia Pollio, Md, MD
Obstetrics & Gynecology — Payments: $740.15
Daniel Vinick, Md, MD
Obstetrics & Gynecology — Payments: $725.10
Dr. Cherie Passano, Md, MD
Obstetrics & Gynecology — Payments: $708.24
Henry Bareket, Md, MD
Obstetrics & Gynecology — Payments: $651.11
Dr. Laurie Solomon, Md, MD
Obstetrics & Gynecology — Payments: $501.68
Dr. Gabriel Tenembaum, M.d, M.D
Obstetrics & Gynecology — Payments: $455.96